Found: 16
Select item for more details and to access through your institution.
TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
- Published in:
- Cell & Tissue Research, 2014, v. 357, n. 1, p. 267, doi. 10.1007/s00441-014-1826-8
- By:
- Publication type:
- Article
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2016, v. 35, p. 1, doi. 10.1186/s13046-016-0316-0
- By:
- Publication type:
- Article
Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients.
- Published in:
- Brain Pathology, 2016, v. 26, n. 1, p. 75, doi. 10.1111/bpa.12274
- By:
- Publication type:
- Article
Characterization and prognostic significance of mortalin, Bcl-2 and Bax in intrahepatic cholangiocarcinoma.
- Published in:
- Oncology Letters, 2018, v. 15, n. 2, p. 2161, doi. 10.3892/ol.2017.7570
- By:
- Publication type:
- Article
Human Mitochondrial Hsp70 (Mortalin): Shedding Light on ATPase Activity, Interaction with Adenosine Nucleotides, Solution Structure and Domain Organization.
- Published in:
- PLoS ONE, 2015, v. 10, n. 1, p. 1, doi. 10.1371/journal.pone.0117170
- By:
- Publication type:
- Article
Knockdown of <i>Hsc70-5/mortalin</i> Induces Loss of Synaptic Mitochondria in a <i>Drosophila</i> Parkinson’s Disease Model.
- Published in:
- PLoS ONE, 2013, v. 8, n. 12, p. 1, doi. 10.1371/journal.pone.0083714
- By:
- Publication type:
- Article
HSPA9/Mortalin mediates axo-protection and modulates mitochondrial dynamics in neurons.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97162-1
- By:
- Publication type:
- Article
Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization.
- Published in:
- Bioscience Reports, 2013, v. 33, n. 5, p. 797, doi. 10.1042/BSR20130034
- By:
- Publication type:
- Article
Mortalin is a prognostic factor of gastric cancer with normal p53 function.
- Published in:
- Gastric Cancer, 2014, v. 17, n. 2, p. 255, doi. 10.1007/s10120-013-0279-1
- By:
- Publication type:
- Article
Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells.
- Published in:
- Oncogene, 2015, v. 34, n. 35, p. 4624, doi. 10.1038/onc.2014.392
- By:
- Publication type:
- Article
Mortalin (GRP75/HSPA9) Promotes Survival and Proliferation of Thyroid Carcinoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2069, doi. 10.3390/ijms20092069
- By:
- Publication type:
- Article
Developmental Expression and Functions of the Small Heat Shock Proteins in Drosophila.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 11, p. 3441, doi. 10.3390/ijms19113441
- By:
- Publication type:
- Article
Mutations in the heat-shock protein A9 (HSPA9) gene cause the EVEN-PLUS syndrome of congenital malformations and skeletal dysplasia.
- Published in:
- Scientific Reports, 2015, p. 17154, doi. 10.1038/srep17154
- By:
- Publication type:
- Article
Virtual screening technique to identify embelin as potent inhibitor of mortalin p-53 tumor suppressor protein.
- Published in:
- Drug Invention Today, 2018, v. 10, n. 10, p. 1992
- By:
- Publication type:
- Article
Targeting Mortalin by Embelin Causes Activation of Tumor Suppressor p53 and Deactivation of Metastatic Signaling in Human Breast Cancer Cells.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0138192
- By:
- Publication type:
- Article
Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase.
- Published in:
- Cancer Cell International, 2014, v. 14, n. 1, p. 1, doi. 10.1186/s12935-014-0069-9
- By:
- Publication type:
- Article